Drugs / SPARC0913
last change Jun 2012 re-read 3 minutes ago

SPARC0913

Developed for
ocular hypertension · open-angle glaucoma
Investigated by
Sun Pharma Advanced Research Company Limited

Trials 1

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00945958 Nov 2010 → Jun 2012 ocular hypertension, open-angle glaucoma Sun Pharma Advanced Research Company Limited Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SPARC0913 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00945958 ↗